Johnson and Johnson bets twelve billion on dental automation
Cash is king. Johnson and Johnson just spent a mountain of it. The healthcare giant announced a $12 billion all-cash…
Cash is king. Johnson and Johnson just spent a mountain of it. The healthcare giant announced a $12 billion all-cash…
The $1.8 Trillion QuestionSpaceX is a black box. It consumes capital and spits out orbital dominance. The $1.8 trillion valuation…
The Index Effect and the Marvell ArbitrageThe tape does not lie. Passive flows are coming. The smart money is already…
The Triple Agonist BreakthroughEli Lilly just moved the goalposts. Again. The Phase 3 data for Retatrutide is not just good.…
The Milanese aggregator heads for New YorkThe filing hit the wires at 11:42 AM. It was not a surprise. It…
Institutional Trust Meets the Musk EffectThe polls closed. The noise started. Los Angeles is a fiscal tinderbox. As the mayoral…
The Institutional Myth of the Exceptional CEOThe marketing is slick. Morgan Stanley recently promoted its Exceptional Leaders series as a…
The Iberian DivergenceMadrid is moving. Brussels is watching. While the core of the Eurozone remains mired in a cycle of…
The Consensus Crumbles Inside the Worlds Largest Asset ManagerThe signal is loud. The noise is fading. BlackRock internal strategists are…
The Institutional PivotBlackRock just blinked. On June 5, the world largest asset manager released a poll of its internal portfolio…